Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03991728
Other study ID # TMJ Replacement
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 15, 2019
Est. completion date December 2027

Study information

Verified date February 2024
Source AO Innovation Translation Center
Contact Alix Frischknecht
Phone +41 79 606 41 48
Email alix.frischknecht@aofoundation.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Prospective data will be collected in approximately 200 patients treated with an TMJ replacement. Patients will be followed up according to the standard (routine) for up to 5 years after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s and anticipated or procedure-related adverse events (i.e. complications). This registry is designed to be able to assess the number of patients who refuse alloplastic total TMJ replacement. Therefore, the participating sites are asked to register all cases of refused TMJ replacements too.


Description:

More in detail this registry has the following objectives: - To describe clinical indications for TMJ replacement, and treatment patterns (including differences among regions if feasible) - To describe the clinical evolution and outcomes of patients treated with a TMJ replacement - To explore the relationship(s) between treatment, outcome(s) and quality of life (QoL). - To identify predictive factors for favorable outcomes (pain reduction, range of motion (ROM), occlusal status, QoL) in patients treated with TMJ replacement. - To describe the reasons of patients who refused TMJ replacements


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2027
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years and or older - Patients requiring alloplastic total TMJ replacement - Informed consent obtained, i.e.: - Ability to understand the content of the patient information/informed consent form (ICF) - Willingness and ability to participate in the registry according to the Registry Plan (RP) - Signed and dated ethics committee (EC) / Institutional review board (IRB) approved written informed consent Exclusion Criteria: - Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment - Pregnancy or women planning to conceive within the study period - Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Design


Related Conditions & MeSH terms

  • Temporomandibular Joint Disorders
  • Temporomandibular Joint Dysfunction Syndrome

Locations

Country Name City State
Brazil Hospital BP - A Beneficência Portuguesa de São Paulo São Paulo
Colombia Estetica Maxilofacial Bogotá
Germany Hannover Medical School Hannover
Germany University Hospital Leipzig Leipzig
Germany Klinikum der LMU München Munich
India Sri Shankara Cancer Hospital and Research Center Bangalore
India All India Institute of Medical Sciences (AIIMS) New Delhi
Netherlands Erasmus Medisch Centrum Rotterdam
New Zealand Waikato DHB Christchurch
New Zealand Hutt Hospital Lower Hutt
Pakistan Mayo Hospital Lahore
Poland Wojewódzki Specjalistyczny Szpital Dzieciecy Olsztyn
Russian Federation National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Healthcare of the Russian Federation Moscow
Serbia Clinic for Maxillofacial Surgery, University of Belgrade Belgrade
South Africa King Edward VIII Hospital Durban
Spain 12 de Octubre University Hospital Madrid
Sweden Falu Hospital Falun
Sweden Skåne University Hospital Lund
Sweden Karolinska University Hospital Stockholm
Sweden Uppsala University Hospital Uppsala
Switzerland Universitätsspital Basel Basel

Sponsors (1)

Lead Sponsor Collaborator
AO Clinical Investigation and Publishing Documentation

Countries where clinical trial is conducted

Brazil,  Colombia,  Germany,  India,  Netherlands,  New Zealand,  Pakistan,  Poland,  Russian Federation,  Serbia,  South Africa,  Spain,  Sweden,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The registry has no primary but several objectives. due to the study design, no primary objective has been defined and therefore no primary outcome measure either from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Demographics Year of birth Gender Smoking pre-operative
Secondary Comorbidities Concomitant diseases will be assessed using the Charlson Comorbidity Index (CCI). This score assesses the comorbidity level by considering both the number and severity of pre-defined comorbid conditions. It provides a weighted score of a patient's comorbidities which can be used to predict mortality rates pre-operative
Secondary Refusal of alloplastic total TMJ replacement surgery For patients who require alloplastic total TMJ replacement but refuse surgery, the reason(s) for refusal will be collected. pre-operative
Secondary Clinical and functional outcomes - Mandibular movements Interincisial opening/maximal opening Lateral movements Protrusive movement from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Clinical and functional outcomes - Occlusal status Occlusion will be assessed according to Angle's classification: from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Clinical and functional outcomes - Dentition Dental status will be recorded as:
Edentulous
Complete dentition
Partial dentition In case of partial dentition, missing teeth will be recorded individually using the Fédération Dentaire Internationale (FDI) tooth numbering formula .
from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Clinical and functional outcomes - Helkimo Clinical dysfunction index The dysfunction of the mandible will be evaluated by means of the Helkimo index. The Helkimo index is based on the assessment of five different symptoms. from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Patient Reported Outcomes - Pain numeric rating scale (NRS) The Pain NRS is an 11-point scale where the end points are the extremes of no pain (0 points), to worst imaginable pain (10 points). It measures subjective intensity of pain and the patient rates his/her overall or average daily pain.
Will be assessed independently for each site.
from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Patient Reported Outcomes - Jaw function NRS The jaw function NRS is an 11-point scale where the end points are the extremes of normal jaw movement (0 points), to no jaw movement (10 points). It measures subjective jaw function. from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Patient Reported Outcomes - Diet limitation NRS The diet limitation NRS is an 11-point scale where the end points are the extremes of no restrictions (0 points), to liquids only (10 points). It measures subjective diet limitations. from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Patient Reported Outcomes - EuroQoL five dimension (EQ-5D-5L) The EQ-5D-5L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months
Secondary Patient Reported Outcomes - Oral Health Impact Profile (OHIP) - 14 The OHIP is concerned with impairment and three functional status dimensions (social, psychological and physical) which represent four of the seven quality of life dimensions proposed by Patrick and Bergner. Hence, it excludes perceptions of satisfaction with oral health, changes in oral health, prognosis or self-reported diagnoses. Furthermore, the OHIP aims to capture impacts that are related to oral conditions in general, rather than impacts that may be attributed to specific oral disorders or syndromes. All impacts in the OHIP are conceptualized as adverse outcomes, and therefore the instrument does not measure any positive aspects of oral health. The OHIP consists of 14 items evaluated using a 5-point Likert from "Never" to "Very often " in which higher scores indicated worse outcomes. It has validated translations to Swedish, Spanish, German, Hindi and further more. from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months
Secondary Anticipated treatment or condition-related adverse events (i.e. complications) In this registry, only anticipated condition, treatment-, or implant-related adverse events (i.e. complications) will be documented in the electronic case report form (eCRF) from the time of consent onwards.
In the context of the registry, these events are considered as events of scientific interest, i.e. events that can clearly be connected to the treatment(s) or the medical condition under investigation. These events do not require immediate reporting unless they occur at a higher frequency and/or severity to that cited in the literature
from the pre-operative assessment until 60 months after surgery (10 days / 3 months / 6 months / 12 months / 24 months / 60 months)
Secondary Survival Follow up (FU) visits will be scheduled and performed according to the local standard of care and at each scheduled visit the patient's survival will be documented. In case a patient misses a scheduled visit, it will be assessed if the patient is still alive, which can be done via phone call. 10 days / 3 months / 6 months / 12 months / 24 months / 60 months
Secondary Radiological parameters - Displacement of ramus component All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and 'displacement of ramus component' evaluated by local investigator: pre-operative / 10 days / 12 months / 24 months
Secondary Radiological parameters - Fracture of ramus component All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and evaluated by local investigator if a 'fracture of the ramus component' occurred pre-operative / 10 days / 12 months / 24 months
Secondary Radiological parameters - Screw loosening All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and evaluated by local investigator if 'screw loosening' occurred pre-operative / 10 days / 12 months / 24 months
Secondary Radiological parameters - Resorption/ osteolysis of surrounding bone All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and 'resorption/ osteolysis of surrounding bone' evaluated by local investigator pre-operative / 10 days / 12 months / 24 months
Secondary Radiological parameters - Status of bone grafts if used (displaced/ resorbed/ healed) All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and 'status of bone grafts if used (displaced/ resorbed/ healed)' evaluated by local investigator pre-operative / 10 days / 12 months / 24 months
Secondary Radiological parameters - Presence of ectopic bone All images (preferably computed tomography (CT) / cone beam (CB) CT scan) taken as part of the standard (routine) will be collected and 'presence of ectopic bone' evaluated by local investigator pre-operative / 10 days / 12 months / 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT03675659 - Intra-articular Magnesium Sulfate for Tmj Dysfunction Early Phase 1
Completed NCT05740826 - Correlation Between Cervical Spine Muscle Disorders and the Occurrence of Symptoms of Temporomandibular Joint Dysfunction
Recruiting NCT05006963 - Tele-Rehabilitation in Patients With Temporomandibular Dysfunction N/A
Active, not recruiting NCT06103851 - Effect of Mask Use on Jaw Functionality
Not yet recruiting NCT02908568 - Stimulation of the Proprioceptive Trigeminocardiac Reflex Phase 2/Phase 3
Completed NCT03119324 - Low Level Laser Therapy in the Treatment of Temporomandibular Joint Disorders (TMJDs) Related Pain N/A
Completed NCT02247063 - Motor Cortex as a Research & Therapeutic Target in TMD N/A
Recruiting NCT06046521 - Impact of Temporomandibular Joint Dysfunction on Objective and Subjective Vocal Measures
Completed NCT00009594 - Alternative Medicine Approaches for Women With Temporomandibular Disorders Phase 2
Completed NCT00010621 - Complementary Medicine Approaches to TMD Pain Management Phase 2
Completed NCT06055855 - Comparing Two-Needle vs. Surgery-Guided Arthrocentesis for TMJ Disorders N/A
Recruiting NCT06035341 - The Association Between Temporomandibular Disorders and Sacroiliac Joint Dysfunction N/A
Completed NCT06005922 - The Effectiveness of Temporomandibular Joint Mobilization and Exercise in Individuals With Chronic Neck Pain N/A
Completed NCT06034756 - Temporomandibular Joint Problems and Core Stabilization
Completed NCT03576079 - Effect of Laser Therapy Versus Anterior Re-positioning Splint in the Treatment of Disc Displacement With Reduction N/A
Completed NCT04557878 - Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction Phase 2
Completed NCT04477122 - Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome. N/A
Completed NCT00237042 - Managing Temporomandibular Disorder (TMD) Symptoms N/A
Completed NCT06132802 - Evaluation of Anterior Repositioning Guided Splint Combined With or Without I Platelet-rich Fibrin N/A
Completed NCT06132594 - Computed Guided Prolotherapy Versus Conventional Prolotherapy N/A